Skip to content
New platform coming soon — AI-Based Analysis with Human-Generated Insights
Stock Target Advisor Stock Target Advisor Market intelligence
  • Research ▾
    • Equity Reports
    • STA Portfolio
    • Top Stocks
  • Market Analysis
  • Analyst Ratings
  • Stock Research Tools ▾
    • Analyst Target Tool
    • Analyst Ranking Tool
    • Stock Analysis Tool
  • About ▾
    • About STA
    • Services
    • Contribute
    • Contact
  • Social Media ▾
    • YouTube
    • Blossom
    • Substack
    • TikTok

Browse research

Tag: Earnings

Mattel Q1 Earnings: Misses Sales Estimates But Beats Loss Forecasts
Market News & Insights Apr 24, 2024

Mattel Q1 Earnings: Misses Sales Estimates But Beats Loss Forecasts

Mattel Inc (MAT: NSD) reported mixed results for its first quarter of 2024. While the company’s net sales fell short of expectations,…

#Earnings
Canadian National Railway Co. (CNR:CA) TD Securities Maintains "Buy" Rating
Market News & Insights Apr 24, 2024

Canadian National Railway (CNR): Earnings Analysis

Canadian National Railway Canadian National Railway (CNR) has recently released its Q1/24 earnings report, showcasing a performance that aligns with expectations and…

#analyst ratings #Canadian Markets #Dividends
Microsoft (MSFT) Oppenheimer Raises Target to $570
Market News & Insights Apr 24, 2024

Microsoft Q3 Earnings: Analysts Bullish Ahead of Report

Microsoft Corporation (MSFT: NYE) is set to report its fiscal third-quarter 2024 earnings on April 25th, and analysts are expressing optimism about…

#Artificial Intelligence #Earnings
Boeing Makes Big Payment to Spirit, But Legal Clouds Remain After Crashes
Market News & Insights Apr 24, 2024

Boeing Makes Big Payment to Spirit, But Legal Clouds Remain After Crashes

Boeing (BA: NYE) has made an agreement with Spirit AeroSystems (SPR: NYE) to pay $425 million in advance.   Families of Crash…

#Earnings
Recursion Pharmaceuticals: A Deep Dive into the AI-Powered Biotech Company
Market News & Insights Apr 24, 2024

Recursion Pharmaceuticals: A Deep Dive into the AI-Powered Biotech Company

Recursion Pharmaceuticals (RXRX: NSD) is a biotech company pioneering the use of artificial intelligence (AI) to accelerate drug discovery. This innovative approach…

#Artificial Intelligence #Earnings #Healthcare Stocks

Posts pagination

Previous 1 … 515 516 517 518 519 … 671 Next
Stock Target Advisor

Timely market news, analyst rating changes, and practical investment research for investors around the world.

  • Research
  • Analyst Ratings
  • Market Analysis
  • Top Stocks
  • About Us
  • Contact Us
  • Contribute a Post
© 2026 Stock Target Advisor. All rights reserved.

STA RESEARCH

Get the STA Research Professional Newsletter

Market outlook, portfolio updates, technical analysis and stock ideas—US$5/month.

See What’s Included →

Monthly subscription. Secure checkout with PayPal.